Allurion Technologies Inc.

As of March 31, 2026, Allurion Technologies Inc. carries a market capitalization of 10.12M, placing it among publicly traded companies globally. Its enterprise value stands at 34.51M, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

As of March 31, 2026, Allurion Technologies Inc. has 999,632.00 shares outstanding.

These figures are as of March 31, 2026. The price-to-sales ratio is 0.55, and the price-to-book ratio stands at -0.13.

These figures are as of March 31, 2026. The EV/Sales ratio of 2.74 reflects the premium investors pay for the company's revenue stream, a useful check when earnings are depressed or negative. These enterprise value multiples are built on an enterprise value of 34.51M versus a market cap of 10.12M, with the gap driven by net debt and cash on the balance sheet.

As of March 31, 2026, Allurion Technologies Inc. maintains a current ratio of 0.30, meaning it holds 0.3x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is -37.79, indicating conservative leverage, while an interest coverage ratio of -14.10 demonstrates limited ability to service its debt obligations.

These figures cover the twelve months ended March 31, 2026. Return on assets (ROA) is negative at -127.26, reflecting losses generated across the asset base. The company generates approximately 141,539.33 in revenue per employee across its workforce of 89.00, a quick read on workforce productivity versus industry peers. Inventory turnover of 2.20 indicates how many times Allurion Technologies Inc. sells and replaces its inventory over a year, a key working capital efficiency ratio.

Over the twelve months ended March 31, 2026, Allurion Technologies Inc. recorded 1,000.00 in income tax expense. The company reported a pretax loss of -33.35M and -33.35M in bottom-line net income, so the effective tax rate carries little signal until profitability returns.

As of the close on October 15, 2026, Allurion Technologies Inc.'s stock has declined approximately 98.46% over the past 52 weeks. The 50-day moving average sits at 1.88, while the 200-day moving average is 10.27.

Over the twelve months ended March 31, 2026, Allurion Technologies Inc. generated 12.60M in revenue and converted that into -33.35M in net income, yielding earnings per share of -49.17. EBITDA reached -25.66M, while operating income came in at -26.61M.

As of March 31, 2026, Allurion Technologies Inc. holds 5.06M in cash and equivalents against 29.45M in total debt, resulting in a net debt position of 23.49M. Total book value stands at -77.91M, with working capital of -25.95M providing operational flexibility.

Allurion Technologies Inc. produced -22.70M in operating cash flow over the twelve months ended March 31, 2026. After subtracting - - in capital expenditures, free cash flow totaled -22.70M - equivalent to -33.47 per share.

Over the twelve months ended March 31, 2026, Allurion Technologies Inc. posted a gross margin of 52.70, reflecting its pricing power and cost economics. The operating margin of -211.22 and net profit margin of -264.74 provide insight into operational efficiency.

These figures cover the twelve months ended March 31, 2026. Free cash flow yield is negative at -330.54: the business is consuming cash rather than generating it, so any dividend is not covered by free cash flow. Total shareholder yield is negative at -72.49, meaning Allurion Technologies Inc. raised more capital through share issuance and new debt than it returned via dividends and buybacks.

Allurion Technologies Inc.'s most recent stock split took place on June 18, 2026 with a 15:1 split ratio.

As of March 31, 2026, Allurion Technologies Inc. has an Altman Z-Score of -33.25, below the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.